Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C36H62O2
CAS Number:
Molecular Weight:
526.88
UNSPSC Code:
12352103
NACRES:
NA.23
PubChem Substance ID:
EC Number:
214-658-3
Beilstein/REAXYS Number:
3179820
MDL number:
Quality Segment
assay
97%
form
liquid crystal
optical activity
[α]25/D −30°, c = 2 in chloroform
mp
74-77 °C (lit.)
transition temp
crystalline phase to smectic phase 77.5 °C, smectic phase to cholesteric phase 79 °C, cholesteric phase to isotropic phase 90 °C
SMILES string
CCCCCCCCC(=O)O[C@H]1CC[C@]2(C)C3CC[C@]4(C)C(CCC4C3CC=C2C1)[C@H](C)CCCC(C)C
InChI
1S/C36H62O2/c1-7-8-9-10-11-12-16-34(37)38-29-21-23-35(5)28(25-29)17-18-30-32-20-19-31(27(4)15-13-14-26(2)3)36(32,6)24-22-33(30)35/h17,26-27,29-33H,7-16,18-25H2,1-6H3/t27-,29+,30+,31-,32+,33+,35+,36-/m1/s1
InChI key
WCLNGBQPTVENHV-MKQVXYPISA-N
Application
- Liquid Crystal Modified Polylactic Acid Improves Cytocompatibility and M2 Polarization of Macrophages to Promote Osteogenesis: A series of composite films were prepared using cholesteryl oleyl carbonate, cholesteryl pelargonate, and polylactic acid for biomedical applications (Z Zheng et al., 2022).
- Site-selective and stereoselective functionalization of non-activated tertiary C–H bonds: Describes the Rh-catalyzed reaction with cholesteryl pelargonate for selective functionalization (K Liao et al., 2017).
- Cholesteryl ester liquid crystal nanofibers for tissue engineering applications: Development of nanofibers using cholesteryl pelargonate for enhanced tissue engineering applications (A Nasajpour et al., 2020).
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.